Disc Medicine, Inc.
IRON · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $87 | $0 | $0 | $9 |
| Gross Profit | -$87 | $0 | $0 | -$9 |
| % Margin | – | – | – | – |
| R&D Expenses | $50,247 | $46,319 | $27,763 | $24,788 |
| G&A Expenses | $17,362 | $15,091 | $12,183 | $9,753 |
| SG&A Expenses | $17,362 | $15,091 | $12,183 | $9,753 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $67,609 | $61,410 | $39,946 | $34,541 |
| Operating Income | -$67,696 | -$61,410 | -$39,946 | -$34,550 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $5,477 | $6,215 | $5,980 | $5,269 |
| Pre-Tax Income | -$62,219 | -$55,195 | -$33,966 | -$29,281 |
| Tax Expense | $102 | $52 | $119 | $176 |
| Net Income | -$62,321 | -$55,247 | -$34,085 | -$29,457 |
| % Margin | – | – | – | – |
| EPS | -1.77 | -1.58 | -1.02 | -0.98 |
| % Growth | -12% | -54.9% | -4.1% | – |
| EPS Diluted | -1.77 | -1.58 | -1.02 | -0.98 |
| Weighted Avg Shares Out | 35,179 | 35,025 | 33,325 | 29,935 |
| Weighted Avg Shares Out Dil | 35,179 | 35,025 | 33,325 | 29,936 |
| Supplemental Information | – | – | – | – |
| Interest Income | $6,412 | $7,057 | $6,880 | $5,838 |
| Interest Expense | $917 | $910 | $897 | $572 |
| Depreciation & Amortization | $87 | $85 | $20 | $9 |
| EBITDA | -$61,215 | -$54,200 | -$33,049 | -$13,251 |
| % Margin | – | – | – | – |